전체 프로그램

ADC 890 · Antibody 4071 · CGT 2714 · 다음 갱신 D-4 · 마지막 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved1,016 programs
AntibodyCurated CorestaleEpizyme, Inc.Phase 3

Mosunetuzumab (Mosunetuzumab)

Relapsed Hematologic Malignancy; Refractory Hematologic Malignancy · FRα

#FR#Antibody#Phase3#BioJungboMoa-pick#monoclonal-antibody+4
Trials 49Status Recruiting
AntibodyLimited DatastaleMridula George, MDPhase 2

Retifanlimab (Retifanlimab)

Anatomic Stage IV Breast Cancer AJCC v8; Locally Advanced Breast Carcinoma · Diffuse Large B-Cell Lymphoma

#DiffuseLargeB-CellLymphoma#Antibody#Phase2#monoclonal-antibody#AnatomicStageIVBreastCancerAJCCv+3
Trials 49Status Recruiting
AntibodyLimited DatastaleBristol-Myers SquibbPhase 2

Belatacept (Belatacept)

Highly Sensitized Prospective Kidney Transplant Recipients · Kidney Transplantation

#KidneyTransplantation#Antibody#Phase2#monoclonal-antibody#HighlySensitizedProspectiveKidne+2
Trials 48Status Active
ADCStandard DatabasestaleADC TherapeuticsPhase 2

Anti-CD19 Antibody-Drug Conjugate (Loncastuximab Tesirine, Loncastuximab Tesirine (Anti-CD19 Antibody-Drug Conjugate))

Diffuse Large B-Cell Lymphoma; High-grade B-cell Lymphoma (HGBCL) · CD19

#CD19#ADC#Phase2#antibody-drug-conjugate#DiffuseLargeB-CellLymphoma+2
Trials 48Status Recruiting
AntibodyLimited DatastaleEpizyme, Inc.Phase 2

Tafasitamab (Tafasitamab)

Relapsed Hematologic Malignancy; Refractory Hematologic Malignancy · Diffuse Large B-Cell Lymphoma

#DiffuseLargeB-CellLymphoma#Antibody#Phase2#monoclonal-antibody#RelapsedHematologicMalignancy+3
Trials 48Status Discontinued
CGTStandard DatabasestaleSun Yat-sen UniversityPhase 2

Relmacabtagene Autoleucel (Autoleucel, Autoleucel (Relmacabtagene Autoleucel))

Large B Cell Diffuse Lymphoma; Mantle Cell Lymphoma (MCL) · Large B Cell Diffuse Lymphoma

#LargeBCellDiffuseLymphoma#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 47Status Recruiting
AntibodyLimited DatastaleChia Tai Tianqing Pharmaceutica…Phase 2

Penpulimab (Penpulimab)

Advanced Malignant Neoplasm · Breast Cancer

#BreastCancer#Antibody#Phase2#monoclonal-antibody#AdvancedMalignantNeoplasm+2
Trials 47Status Active
ADCStandard DatabasestaleAstellasPhase 3

EV/P (enfortumab vedotin and pembrolizumab, enfortumab vedotin and pembrolizumab (EV/P))

Advanced Bladder Cancer · Advanced Bladder Cancer

#AdvancedBladderCancer#ADC#Phase3#antibody-drug-conjugate#ADCsandimmunotherapyhavechangedt+1
Trials 47Status Recruiting
CGTLimited DatastaleVaxcell Bio, Co., Ltd.Phase 1

Autologous Natural Killer Cell Therapy (Autologous Natural Killer Cell Therapy)

Hepatocellular Carcinoma · Hepatocellular Carcinoma

#HepatocellularCarcinoma#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 46Status Recruiting
CGTStandard DatabasestaleCenter for International Blood …Phase 2

Chronic Myeloid Leukemia + NK cell (Chronic Myeloid Leukemia + NK cell)

Chronic Myeloid Leukemia · Chronic Myeloid Leukemia

#ChronicMyeloidLeukemia#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 46Status Active
CGTLimited DatastaleGeneplus-Beijing Co. Ltd.Phase 2

DC-CIK (DC-CIK)

Renal Cell Carcinoma · Renal Neoplasma

#RenalNeoplasma#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 46Status Recruiting
CGTLimited DatastaleWuhan Sian Medical Technology C…Phase 2

Second generation CAR-T cells (Second generation CAR-T cells)

Acute Lymphoblastic Leukemia; B Cell Lymphoma · Acute Lymphoblastic Leukemia

#AcuteLymphoblasticLeukemia#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 46Status Active
CGTLimited DatastaleHistograft Co., Ltd.Preclinical

"Histograft", a bone substitute based on octacalcium phosphate (OCP, "Histograft", a bone substitute based on octacalcium phosphate, "Histograft", a bone substitute based on octacalcium phosphate (OCP) and plasmid DNA encoding VEGFA gene)

Non Union Fracture; Non-Union of Ankle Joint Without Infection · FRα

#FR#CGT#Preclinical#cell-gene-therapy#CAR-T+5
Trials 45Status Active
CGTLimited DatastaleSecuraBioPhase 1

Duvelisib (Duvelisib)

Recurrent Diffuse Large B-Cell Lymphoma; Refractory Diffuse Large B-Cell Lymphoma · FRα

#FR#CGT#Phase1#cell-gene-therapy#CAR-T+5
Trials 45Status Active
CGTStandard DatabasestaleNovartisPhase 3

tisagenlecleucel (Kymriah, tisa-cel)

DLBCL; Diffuse Large B Cell Lymphoma · FRα

#FR#CGT#Phase3#cell-gene-therapy#CAR-T+5
Trials 45Status Recruiting
CGTStandard DatabasestaleInnovative Cellular Therapeutic…Phase 2

CART-19 (CART-19)

Hematopoietic/Lymphoid Cancer; Adult Acute Lymphoblastic Leukemia in Remission · B Cell Leukemia

#BCellLeukemia#CGT#Phase2#cell-gene-therapy#CAR-T+5
Trials 44Status Active
AntibodyLimited DatastaleNew Approaches to Neuroblastoma…Phase 1

Dinutuximab (Dinutuximab)

Neuroblastoma · Neuroblastoma

#Neuroblastoma#Antibody#Phase1#monoclonal-antibody#NKcellsbyacombinatorialimmunothe+1
Trials 44Status Recruiting
CGTStandard DatabasestaleThe Methodist Hospital Research…Phase 2

gene therapy (ADV/HSV-tk, ADV/HSV-tk (gene therapy))

Glioblastoma; Anaplastic Astrocytoma · Glioblastoma

#Glioblastoma#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 42Status Recruiting
AntibodyLimited DatastaleRochePhase 3

Ocrelizumab, Rituximab, Ofatumumab (Anti-CD20 therapies, Anti-CD20 therapies (Ocrelizumab, Rituximab, Ofatumumab))

Relapsing-Remitting Multiple Sclerosis (RRMS); Anti-CD20 Therapy · CD20

#CD20#Antibody#Phase3#monoclonal-antibody#Relapsing-RemittingMultipleScler+3
Trials 40Status Recruiting
CGTStandard DatabasestaleOHSU Knight Cancer InstitutePhase 2

Hyper-CVAD (Hyper-CVAD)

Relapsed/Refractory; B-cell Acute Lymphocytic Leukemia · FRα

#FR#CGT#Phase2#cell-gene-therapy#CAR-T+5
Trials 40Status Recruiting

6 / 51 pages

← PreviousNext →